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Abstract 
Background/objective: Previously published literature assessing the reporting of outcome 
measures used in joint replacement randomised controlled trials  (RCTs) has revealed 
disappointing results.  It remains unknown as to whether international initiatives have led to any 
improvement in the quality of reporting and/or a reduction in the heterogeneity of outcome 
measures used. Our objective was to systematically assess and compare primary outcome 
measures and risk of bias of joint replacement RCTs published in 2008 and 2013.  
Methods: We searched MEDLINE, EMBASE and CENTRAL for RCTs investigating adult 
patients undergoing joint replacement surgery. Two authors independently identified eligible 
trials, extracted data and assessed risk of bias using the Cochrane tool.  
Results: Seventy RCTs  (30 in 2008; 40 in 2013) met the eligibility criteria.  There was no 
significant difference in the number of trials judged to be at low overall risk of bias  (N=6, 20%) 
in 2008 compared with six  (15%) in 2013  (χ
2
=0.302, P=0.75). Significantly more trials 
published in 2008 did not specify a primary outcome measure  (N=25, 83%) compared with 18  
(45%) trials in 2013, χ
2
= 10.6316, P=0.001).  When specified, there was significant 
heterogeneity in the measures used to assess primary outcomes.  
Conclusion:  While less than a quarter of trials published in both 2008 and 2013 were judged to 
be at low overall risk of bias, significantly more trials published in 2013 specified a primary 
outcome. Although this might represent a temporal trend towards improvement, the overall 
frequency of primary outcome reporting and the wide heterogeneity in primary outcomes 
reported remain suboptimal.  
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Introduction 
With an expanding and aging population, an escalating prevalence of obesity and a rising need 
for both initial and joint revision surgery, the incidence and associated economic burden of joint 
replacement surgery has been projected to increase exponentially(1). For many patients, joint 
replacement surgery is an effective management option to reduce pain, restore function and 
improve quality of life. However, individuals who undergo joint replacement are also at risk for 
a variety of adverse events associated with both the anaesthetic and the surgery. With expanding 
indications for joint replacement and the continuing evolution of surgical techniques and 
implants, many important research questions need to be answered. To address these issues there 
is an ongoing need for high quality trials within this field of orthopaedics. 
 
Randomised controlled trials  (RCTs) are widely acknowledged to be the best type of trial design 
to evaluate the effectiveness and safety of health care interventions.(2-5) However, the RCT’s 
ability to answer important clinical questions will always be limited by its design and the 
outcome measures used. To draw meaningful conclusions from individual RCTs, relevant, robust 
and validated outcomes measures are required. In addition, these outcomes should be pre-
specified and clearly reported as to whether they are primary or secondary. This enables readers 
to assess whether the RCT is adequately powered and avoids the perception of selective 
reporting bias. 
 
In the field of joint replacement surgery, previously published literature assessing the reporting 
frequency, relevance and homogeneity of outcome measures used has revealed disappointing 
results(6).  Specifically, primary outcomes were often not specified, and when they were, there 
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was significant heterogeneity in the types of outcomes measures used to assess the same 
endpoint.  To address this on a large scale, several multi-national collaborations and initiatives 
have been established. For example, following the poor findings in their systematic review, 
Riddle and colleagues proposed that consensus from an international group of experts involved 
in the care of these patients was needed(7). In 2008 a working group within Outcome Measures 
in Rheumatology  (OMERACT) and Osteoarthritis Research Society International  (OARSI) was 
established with the aim of improving the reporting of relevant, evidence based health outcome 
domains within joint replacement trials(8).  In addition, to facilitate accurate, complete, and 
transparent reporting of all clinical trials, in 2008 the EQUATOR  (Enhancing the Quality and 
Transparency of Health Research) Network was launched and in 2010 the Consolidated 
Standards of Reporting Trials  (CONSORT) Statement  (first published in 1996) was published 
to provide researchers with a check list of 25 items to facilitate complete and transparent 
reporting of trial findings(9).   
 
It remains unknown as to whether these international initiatives have led to any improvement in 
the quality of joint replacement trial reporting and/or a reduction in the heterogeneity of outcome 
measures used. To investigate this question and inform the OMERACT 2014 Working Group 
meeting  (which aimed to define an internationally agreed upon core set of domains and outcome 
measures that should be reported in every joint replacement clinical trial)(10), we performed a 
systematic review of outcomes that had been reported in joint replacement trials published in 
2008 and 2013. This paper reports the risk of bias of included trials and assesses and compares 
their primary outcomes. A separate paper will report the extent to which all reported outcomes 
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met the OMERACT criteria of truth, discrimination, and feasibility and map the reported 
outcomes to OMERACT Filter 2.0(11).  
 
Methods  
Search Strategy and Criteria 
This systematic review was performed in accordance with the PRISMA  (Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses) format(12) and the protocol was 
prospectively registered with the International Prospective Register of Systematic Reviews  
(PROSPERO) Registration number: CRD42014009216.  This study did not require ethics 
committee approval , since it does not involve any human or animals and is a systematic review 
of published articles in the medical literature.  
 
All randomised or quasi-randomised  (where allocation not strictly random) controlled trials 
investigating adult patients undergoing joint replacement surgery  (defined as substitution of any 
joint surface with a prosthesis) were identified. Trials were included if the comparator was 
another type of joint implant, surgical placebo or sham, usual care, physical therapy or other 
active treatment and at least one outcome had been reported. Studies were excluded if they 
evaluated spinal joint replacement surgery, had a primary intervention of interest that was not the 
insertion of a joint prosthesis  (e.g. trials investigating pre-operative education, peri-operative 
analgesia or post-operative care) or were not published as a full report in English.  
 
An electronic literature search for articles published in 2008 and 2013 was performed in 
MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials  (CENTRAL) 
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using a comprehensive search strategy  (Supplementary Table 1). We also performed a hand 
search of reference lists of relevant articles to identify additional relevant trials.  
 
Two authors  (BR and PW) independently screened the titles and abstracts of all studies 
identified by the search strategy and then independently reviewed the full text of all potentially 
eligible studies to identify studies that fulfilled inclusion criteria. Any disagreement in study 
selection was resolved by consensus or by discussion with a third reviewer (RB). 
 
The same two authors independently extracted data from the included using predetermined 
forms. Differences in data extraction were resolved by referring back to the original articles and 
establishing a consensus. A third reviewer  (RB) was consulted to help resolve differences as 
necessary. The information extracted included study site, funding, enrolment date, size, design, 
population, interventions, and outcome measures  (and whether they were pre-specified). Each 
outcome was recorded as either primary or secondary. An outcome was recorded as primary if it 
was reported as a “primary outcome” in the manuscript or registered protocol or was used to 
calculate the sample size. More than one primary outcome could be recorded provided these 
criteria were met.  
 
Two authors  (BR and PW) independently assessed risk of bias for all included studies using 
methods recommended by the Cochrane Collaboration,(13) which assess the following key 
criteria: random sequence generation, allocation concealment, blinding of participants, care 
provider and outcome assessor for each outcome measure, incomplete outcome data, selective 
outcome reporting  and other sources of bias. Other sources of bias that were considered included 
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whether or not co-interventions and adherence to treatment (e.g. for analgesics and physical 
therapy programs) were assessed and reported to be equal between groups, and sources of 
funding. Each criterion was rated as low risk of bias, high risk of bias, or unclear risk  (indicating 
either lack of information or uncertainty over the potential for bias). Information to inform the 
risk of bias rating was sourced from searching trial registries and the published papers. 
An assessment of overall risk of bias was made where low overall risk of bias indicated plausible 
bias unlikely to seriously alter the results  (low risk of bias for all key domains), unclear overall 
risk of bias indicated plausible bias that raises some doubt about the results  (unclear risk of bias 
for one or more key domains) and high overall risk of bias indicating plausible bias seriously 
weakens confidence in the results  (high risk of bias for one or more key domains)(13). A third 
reviewer  (RB) was consulted to resolve differences as necessary.  
Data Analysis 
A descriptive analysis of the primary outcomes was p rformed which compared frequency and 
description of primary outcome measures by site of joint replacement and year. Comparison of 
2008 and 2013 results for overall risk of bias and number of trials reporting primary outcomes 
was made using Pearson chi-squared tests. We also used the Pearson chi-squared test to 
determine whether an association might exist between overall risk of bias and reporting of 
primary outcomes. 
 
Results 
The search strategy identified 1635 studies. Of these 70 randomised controlled trials  (30 with 
2,789 participants published in 2008 and 40 with 4253 participants published in 2013), met the 
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eligibility criteria and were included in the review. A PRISMA flow diagram of the searches 
through to the final inclusion is shown in Figure 1. The summary characteristics of the included 
trials according to their year of publication are shown in Table 2. 
 
Study characteristics of trials published in 2008 
Eighteen  (60%) of the 30 trials published in 2008 were conducted in Europe (14-26), six (20%) 
in the USA(27-32), two (7%) each in Asia(33, 34) and Canada (35, 36) and one (3%) each in 
Australia(37) and New Zealand(38). Twenty (67%) trials were independently funded(14-17, 19, 
20, 22-24, 26-28, 30-32, 34, 35, 37-39) , 9 (30%) had industry funding(17, 18, 21, 29, 31, 36, 40-
42) and in one trial the source of funding was unclear(25). The year of first recruitment ranged 
from 1994 to 2007 (median, 2001). The most common joint evaluated was the knee  (N= 19, 
63%)(17-24, 26, 29, 30, 33-37, 39, 42, 43), followed by the hip  (N=10, 33%)(14-16, 27, 28, 31, 
32, 38, 40, 41), and one trial (3%) evaluated the shoulder(25).  There were no trials evaluating 
joint replacement surgery of the elbow, wrist, hand, ankle or foot. Fifteen (50%) trials evaluated 
two or more different prostheses or components(14, 16-19, 25, 26, 30, 31, 38-43), 13 (43%) 
evaluated the same prosthesis but used differing surgical techniques(20-24, 27-29, 33-37) and 
two (1%) evaluated joint replacement versus other joint surgeries(15, 32).  
 
Study Characteristics of trials published in 2013 
Twenty  (50%) of the 40 trials published in 2013 were conducted in Europe(44-63), nine (23%) 
in Asia(64-71), five (13%) in the USA(72-76), four (10%) in Canada(77-80), and one (3%) each 
in Australia(81) and the Middle East(82). Twelve (30%) trials were industry funded(45, 52, 54-
56, 59, 62, 63, 70, 73, 77, 80), 15 (38%) had independent funding(44, 46, 48, 50, 51, 53, 57, 60, 
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64, 65, 69, 72, 78, 81, 82) and in 13 (33%) trials the source of funding was not specified(47, 49, 
58, 61, 66-68, 70, 71, 74-76, 79). The year of first recruitment ranged from 1996 to 2011  
(median, 2007). The knee (n= 20, 50%)(45, 48, 49, 54, 55, 57, 61, 64-66, 68-71, 73-76, 81) and 
hip  (N=17, 43%)(44, 46, 47, 51-53, 56, 58-60, 62, 63, 67, 72, 77, 79, 80) were again the most 
commonly studied joints, with two trials (5%) studying the shoulder(78, 82) and one (3%) 
studying the wrist(50).  There were no trials evaluating joint replacement surgery of the elbow, 
hand, ankle or foot. Eighteen (43%) trials evaluated two or more different prostheses or 
components(44, 45, 47-50, 52, 54, 56, 57, 61-64, 67, 73, 79, 80), 20 (50%) evaluated the same 
prosthesis but used differing surgical techniques(53, 55, 58-60, 65, 66, 68-72, 74-78, 81, 82) and 
two (5%) evaluated joint replacement versus other joint surgeries(46, 51). 
 
Risk of Bias 
Of the 30 trials published in 2008, 6 (20%) were judged to be at low overall risk of bias, and the 
remainder were all judged to be at high or unclear overall risk of bias (Figure 2). Four (21%) of 
the 19 knee trials(36, 39, 42, 43), and 2 (20%) of the 10 hip trials were judged to be low risk of 
bias(40, 41). In the one shoulder joint trial(25), the risk of bias was deemed unclear. 
 
Of the 40 trials published in 2013, only six (15%) were judged to be at low overall risk of bias  
(Figure 3). Three (15%) of the 20 knee trials were judged to be at low overall risk of bias(56, 58, 
77), 11 (55%) were deemed unclear(48, 57, 64, 66, 68-70, 73, 76, 81) and 6 (30%) were judged 
to be at high risk of bias(49, 54, 61, 71, 74, 75). Three  (21%) of the 17 hip trials were judged to 
be at low overall risk of bias(56, 58, 77), six  (43%) were deemed unclear(46, 47, 59, 60, 62, 80) 
and eight  (57%) were judged to be at high risk of bias(44, 51-53, 63, 67, 72, 79).  One shoulder 
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trial was deemed unclear(82) and one was judged to be at high overall risk of bias(78), while the 
single wrist trial was also judged to be at high overall risk of bias(50).  
 
Figure 4 compares the number of trials with low risk of bias for each risk of bias domain and 
overall low risk of bias according to publication year. There was no difference between years in 
number of trials judged to be at overall low risk of bias (6/30 in 2008 compared with 6/40 in 
2013, χ
2
 0.302, P=0.75). The method used to generate the random sequence was adequately 
reported in 63% of the 2008 trials and 53% of the 2013 trials, however details of allocation 
concealment were reported in only 10 (33%) trials in 2008 and 12 (30%) trials in 2013. More 
trials reported blinding of patients (13, 33%) and outcomes (N=14, 35%) in 2013 in comparison 
with 2008 (N=17 (23%) and 4  (13%) respectively).  Twenty-six (87%) trials in 2008 reported 
detailed baseline characteristics however this only applied to 22 (55%) of the 2013 trials. Few 
trials pre-specified or reported the use of relevant co-interventions (N=13, 43%) in 2008; N=9, 
22% in 2013), or described how incomplete data were addressed  (N=4, 13% in 2008; N=14, 
35% in 2013). Several trials also had evidence of selective outcome reporting (N=11, 37% in 
2008; N=9, 22% in 2013). These issues may have influenced outcomes.  
 
Primary Outcomes 
A summary of the primary outcomes reported in the 2008 and 2013 trials is shown in Table 3. 
Compared with trials published in 2008, more trials published in 2013 reported a primary 
outcome  (N=22/40 (55%) compared with N=5/30 (17%), χ
2
= 10.6316, P=0.001). Four out of 19  
(21%) knee trials specified a primary outcome in 2008 compared with 11/20 (55%) knee trials in 
2013. In these 15 knee trials, 17 different primary outcomes were specified despite evaluating 
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similar questions. Within each time period only two trials reported the same primary outcome  
(knee range of motion was specified in two trials in 2008 and difference in mechanical axis 
deviation measured in degrees in the coronal plane on x-ray in two trials in 2013). No primary 
outcome was used in both time periods. The majority of primary outcomes reported evaluated 
technical aspects of the procedures (N=12/17, 71%), rather than patient centred outcomes. 
 
Only one out of 10 (10%) hip trials reported a primary outcome in 2008 compared with 8/17  
(47%) hip trials in 2013.  Similar to the knee trials, the primary outcomes varied widely and were 
focussed on technical outcomes of the procedure. Primary outcomes used in more than one hip 
trial included component migration  (RSA) (N=3), deviation ≥5 degrees of planned stem shaft 
angle  (x-ray) (N=2), computerized gait assessment  (mean gait velocity, stride length) (N=2) and 
revision rates (N=2). Assessment of component migration was the only primary outcome 
measure utilised in both time periods. 
 
Two of the three shoulder trials reported a primary outcome. Only the two 2013 trials evaluating 
shoulder joint replacement surgery reported a primary outcom , and each trial used a different 
measures to assess “improvement”  (post-operative pain on a VAS 0-10mm and healing rate of 
the subscapularis tendon visualised on MRI). The single wrist trial reported a primary outcome 
and used RSA to measure component migration in mm. 
 
Discussion 
We observed a significant difference in the frequency of reporting of primary outcomes in joint 
replacement trials in 2013 compared with 2008. Only 17% (21% knee and 10% hip) of RCTs 
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published in 2008 reported a primary outcome measure in comparison with 55% (55% knee and 
47% hip) in 2013.  Without knowledge of the frequency of reporting before 2008 and between 
2008 and 2013 it is not possible to know with certainty whether or not the improved reporting in 
2013 reflects a real improvement over time. Nevertheless almost half of all joint replacement 
trials continue to fail to specify a primary outcome despite widely accepted CONSORT 
recommendations(9, 83). Similar inadequate reporting of primary outcomes have been shown in 
other surgical fields including ophthalmic surgery(84), solid organ transplantation(85), plastic 
surgery(86), urology(87), trauma surgery(88) and neurosurgery(89). 
  
In addition, we found that among trials that did specify one or more primary outcomes, these 
varied widely despite the trials addressing similar research questions. In both years  (2008 and 
2013), no primary outcome measure was used in more than two trials despite similar research 
questions. This heterogeneity in primary outcome reporting is consistent with results from a 
previous systematic review(6).  Heterogeneity in outcome measurement hampers our ability to 
combine, contrast and accurately interpret the results from multiple RCTs answering the same  
(and sometimes, similar) research questions. To improve the quality of information available for 
patients undergoing joint replacement surgery, RCTs evaluating the same clinical questions need 
to utilise a homogenous set of outcome measures. Further efforts are required to achieve this(10).   
 
Furthermore, the majority of primary outcomes reported were predominantly focussed upon 
technical aspects of the surgery. Hence, despite the significant investment of time, money and 
resources in evaluating these important research questions, we found that the majority of trials in 
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this systematic review were not designed nor powered to evaluate other important core domains 
of health for both the patient and society.   
 
Few trials published in both 2008 and 2013 were judged to be at low overall risk of bias  (20% in 
2008 and 15% in 2013). Not surprisingly, the trials at less potential for bias were more likely to 
report a primary outcome measure. In addition almost a quarter of the trials we included trials  
(20/70, 23%) were judged to be at unclear risk of bias as they reported insufficient information.  
While it is often not possible in surgical RCTs to blind the investigators to the group 
assignments, or standardize surgical techniques, it should be possible to minimise other potential 
sources of bias. Common areas of potential bias occurring in more than 50% of the studies 
included failing to describe allocation concealment, participant blinding, how incomplete data 
were addressed, and selective reporting of outcomes. Lack of adequate reporting of details of 
randomisation, allocation concealment, blinding, co-intervention use and outcomes is not limited 
to joint replacement trials or orthopaedic surgery(84, 87-93). 
 
Our study has several limitations. Firstly, while we used a comprehensive systematic search 
strategy to identify all relevant studies, we excluded foreign language publications. Given the 
high proportion of papers published in English language journals  (80–90%) this is unlikely to 
affect generalisability(94). Secondly, the majority of joint replacement trials in this review 
involved hip and knee surgery. There were limited trials evaluating the shoulder, wrist and hand, 
and no trials evaluating elbow or ankle joint replacement. Therefore our results may or may not 
be generalisable to joint replacement trials of other joints. Thirdly, in selecting two publication 
years, there is a possibility that this literature may not have been truly representative of periods 
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just before, between and after these dates. The five year gap between study years may not have 
been long enough to capture meaningful change; however we chose the start year as the year of 
publication of the study that showed poor quality of arthroplasty trials (6). More studies may be 
needed in the future with a longer interval to look for improvements using the same quality 
criteria. Our results are however consistent with previous reviews. Finally, we judged risk of bias 
and specification of primary outcomes on the basis of the published paper. It may be that we 
overestimated potential for bias and underestimated frequency of primary outcome specification 
due to poor reporting practices rather than suboptimal trial methodology. However we tried to 
limit this effect by also searching the trial registries for protocols.  
 
In conclusion, despite an observed increase in frequency of reporting of primary outcome 
measures in joint replacement trials in 2013 compared with 2008, almost 50% of trials published 
in 2013 did not report their primary outcomes. In addition among trials that did report primary 
outcomes, these were heterogeneous, frequently measured technical aspects of surgery rather 
than patient important endpoints and few trials used the same primary outcome even for similar 
research questions. In addition the majority of trials published in both years were at high or 
unclear overall risk of bias and reflect a lack of implementation of quality improvement 
initiatives such as the CONSORT guidelines  (or similar). Further efforts are needed to improve 
the quality of joint replacement trials and ensure primary outcomes are reported. A standardised, 
universally accepted core set of outcomes to be used in all joint replacement trials, based upon 
their clinical relevance would enhance this field.  
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him as an orthopaedic surgeon with immense enthusiasm for research and for robust clinical 
evidence in the field of joint replacement surgery. He was an integral part of the Working group 
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Page 16 of 51
For Peer Review
 
 17 
References 
1. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee 
arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007;89:780-5. 
2. Britton A, McKee M, Black N, McPherson K, Sanderson C, Bain C. Choosing between randomised 
and non-randomised studies: a systematic review. Health Technol Assess 1998;2:i-iv, 1-124. 
3. Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R. Barriers to participation in 
randomised controlled trials: a systematic review. J Clin Epidemiol 1999;52:1143-56. 
4. Mapstone J, Elbourne D, Roberts I. Strategies to improve recruitment to research studies. 
Cochrane Database Syst Rev 2007:MR000013. 
5. Treweek S, Mitchell E, Pitkethly M, Cook J, Kjeldstrom M, Taskila T, et al. Strategies to improve 
recruitment to randomised controlled trials. Cochrane Database Syst Rev 2010:MR000013. 
6. Riddle DL, Stratford PW, Bowman DH. Findings of extensive variation in the types of outcome 
measures used in hip and knee replacement clinical trials: a systematic review. Arthritis Rheum 
2008;59:876-83. 
7. Riddle DL, Stratford PW, Singh JA, Strand CV. Variation in outcome measures in hip and knee 
arthroplasty clinical trials: a proposed approach to achieving consensus. J Rheumatol 2009;36:2050-6. 
8. Gossec L, Paternotte S, Bingham CO, 3rd, Clegg DO, Coste P, Conaghan PG, et al. 
OARSI/OMERACT initiative to define states of severity and indication for joint replacement in hip and 
knee osteoarthritis. An OMERACT 10 Special Interest Group. J Rheumatol 2011;38:1765-9. 
9. Schulz KF, Altman DG, Moher D, Group C. CONSORT 2010 statement: updated guidelines for 
reporting parallel group randomised trials. Int J Surg 2011;9:672-7. 
10. Singh JA, Dohm M, Sprowson AP, Wall PD, Richards BL, Gossec L, et al. Outcome Domains and 
Measures in Total Joint Replacement Clinical Trials: Can We Harmonize Them? An OMERACT 
Collaborative Initiative. J Rheumatol 2015;42:2496-502. 
11. Boers M, Kirwan JR, Wells G, Beaton D, Gossec L, d'Agostino MA, et al. Developing core outcome 
measurement sets for clinical trials: OMERACT filter 2.0. J Clin Epidemiol 2014;67:745-53. 
12. Moher D, Liberati A, Tetzlaff J, Altman DG, The PG. Preferred reporting items for systematic 
reviews and meta-analyses: the PRISMA Statement. Open Med 2009;3:e123-30. 
13. Higgins JPT, Green S, (editors). Cochrane Handbook for Systematic Reviews of Interventions 
Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from 
http://www.cochrane-handbook.org.2011. 
14. Hamadouche M, Baque F, Lefevre N, Kerboull M. Minimum 10-year survival of Kerboull 
cemented stems according to surface finish. Clin Orthop Rel Res 2008;466:332-9. 
15. Mouzopoulos G, Stamatakos M, Arabatzi H, Vasiliadis G, Batanis G, Tsembeli A, et al. The four-
year functional result after a displaced subcapital hip fracture treated with three different surgical 
options. Int Orthop 2008;32:367-73. 
16. Garcia-Rey E, Garcia-Cimbrelo E, Cruz-Pardos A, Ortega-Chamarro J. New polyethylenes in total 
hip replacement: a prospective, comparative clinical study of two types of liner. J Bone Joint Surg Br 
2008;90:149-53. 
17. Breugem SJM, Sierevelt IN, Schafroth MU, Blankevoort L, Schaap GR, Van Dijk CN. Less anterior 
knee pain with a mobile-bearing prosthesis compared with a fixed-bearing prosthesis. Clin Orthop Rel 
Res 2008;466:1959-65. 
18. Findlay IA, Bowman NK, Miles K, East DJ, Apthorp HD, Butler-Manuel A. The AGC total knee 
replacement-cemented versus cementless hydroxyapatite fixation. J Bone Joint Surg Br 2008;90-
A:Supplement. 
Page 17 of 51
For Peer Review
 
 18 
19. Hansson U, Ryd L, Toksvig-Larsen S. A randomised RSA study of Peri-Apatite HA coating of a total 
knee prosthesis. Knee 2008;15:211-6. 
20. Karachalios T, Giotikas D, Roidis N, Poultsides L, Bargiotas K, Malizos KN. Total knee replacement 
performed with either a mini-midvastus or a standard approach: A prospective randomised clinical and 
radiological trial. J Bone Joint Surg Br 2008;90:584-91. 
21. Lutzner J, Krummenauer F, Wolf C, Gunther KP, Kirschner S. Computer-assisted and 
conventional total knee replacement: a comparative, prospective, randomised study with radiological 
and CT evaluation. J Bone Joint Surg Br 2008;90:1039-44. 
22. Oberst M, Bertsch C, Konrad G, Lahm A, Holz U. CT analysis after navigated versus conventional 
implantation of TKA. Arch Orthop Trauma Surg 2008;128:561-6. 
23. Lozano LM, Segur JM, Macule F, Nunez M, Torner P, Castillo F, et al. Intramedullary versus 
extramedullary tibial cutting guide in severely obese patients undergoing total knee replacement: a 
randomized study of 70 patients with body mass index >35 kg/m2. Obesity Surgery 2008;18:1599-604. 
24. Luring C, Beckmann J, Haibock P, Perlick L, Grifka J, Tingart M. Minimal invasive and computer 
assisted total knee replacement compared with the conventional technique: A prospective, randomised 
trial. Knee Surg Sports Traumatol Arthrosc 2008;16:928-34. 
25. Fialka C, Stampfl P, Arbes S, Reuter P, Oberleitner G, Vecsei V. Primary hemiarthroplasty in four-
part fractures of the proximal humerus: Randomized trial of two different implant systems. J Shoulder 
Elbow Surg 2008;17:210-5. 
26. Therbo M, Lund B, Jensen KE, Schroder HM. Effect of bioactive coating of the tibial component 
on migration pattern in uncemented total knee arthroplasty: A randomized RSA study of 14 knees 
presented according to new RSA-guidelines. J Orthop Traumatol 2008;9:63-7. 
27. Meneghini RM, Smits SA, Swinford RR, Bahamonde RE. A Randomized, Prospective Study of 3 
Minimally Invasive Surgical Approaches in Total Hip Arthroplasty. Comprehensive Gait Analysis. J 
Arthroplasty 2008;23:68-73. 
28. Pagnano MW, Trousdale RT, Meneghini RM, Hanssen AD. Slower recovery after two-incision 
than mini-posterior-incision total hip arthroplasty: A randomized clinical trial. J Bone Joint Surg Am 
2008;90:1000-6. 
29. Lionberger DR, Weise J, Ho DM, Haddad JL. How does electromagnetic navigation stack up 
against infrared navigation in minimally invasive total knee arthroplasties? J Arthroplasty 2008;23:573-
80. 
30. Hall J, Copp SN, Adelson WS, D'Lima DD, Colwell CW, Jr. Extensor mechanism function in single-
radius vs multiradius femoral components for total knee arthroplasty. J Arthroplasty 2008;23:216-9. 
31. Lachiewicz PF, Kelley SS, Soileau ES. Survival of polished compared with precoated roughened 
cemented femoral components: A prospective, randomized study. J Bone Joint Surg Am 2008;90:1457-
63. 
32. Macaulay W, Nellans KW, Garvin KL, Iorio R, Healy WL, Rosenwasser MP, et al. Prospective 
randomized clinical trial comparing hemiarthroplasty to total hip arthroplasty in the treatment of 
displaced femoral neck fractures: winner of the Dorr Award. J Arthroplasty 2008;23:2-8. 
33. Han I, Seong SC, Lee S, Yoo JH, Lee MC. Simultaneous bilateral MIS-TKA results in faster 
functional recovery. Clin Orthop Relat Res 2008;466:1449-53. 
34. Dutton AQ, Yeo S-J, Yang K-Y, Lo N-N, Chia K-U, Chong H-C. Computer-assisted minimally 
invasive total knee arthroplasty compared with standard total knee arthroplasty. A prospective, 
randomized study. J Bone Joint Surg Am 2008;90:2-9. 
35. Harato K, Bourne RB, Victor J, Snyder M, Hart J, Ries MD. Midterm comparison of posterior 
cruciate-retaining versus -substituting total knee arthroplasty using the Genesis II prosthesis. A 
multicenter prospective randomized clinical trial. Knee 2008;15:217-21. 
Page 18 of 51
For Peer Review
 
 19 
36. Chaudhary R, Beaupre LA, Johnston DWC. Knee range of motion during the first two years after 
use of posterior cruciate-stabilizing or posterior cruciate-retaining total knee prostheses: A randomized 
clinical trial. J Bone Joint Surg Am 2008;90:2579-86. 
37. Smith AJ, Wood DJ, Li MG. Total knee replacement with and without patellar resurfacing: a 
prospective, randomised trial using the profix total knee system. J Bone Joint Surg Br 2008;90:43-9. 
38. Pitto RP, Bhargava A, Pandit S, Munro JT. Retroacetabular stress-shielding in THA. Clin Orthop 
Relat Res 2008;466:353-8. 
39. Wylde V, Learmonth I, Potter A, Bettinson K, Lingard E. Patient-reported outcomes after fixed- 
versus mobile-bearing total knee replacement: a multi-centre randomised controlled trial using the 
Kinemax total knee replacement. J Bone Joint Surg Br 2008;90:1172-9. 
40. Glyn-Jones S, Isaac S, Hauptfleisch J, McLardy-Smith P, Murray DW, Gill HS. Does highly cross-
linked polyethylene wear less than conventional polyethylene in total hip arthroplasty? A double-blind, 
randomized, and controlled trial using roentgen stereophotogrammetric analysis. J Arthroplasty 
2008;23:337-43. 
41. Glyn-Jones S, McLardy-Smith P, Gill HS, Murray DW. The creep and wear of highly cross-linked 
polyethylene: A three-year randomised, controlled trial using radiostereometric analysis. J Bone Joint 
Surg Br 2008;90:556-61. 
42. Nutton RW, van der Linden ML, Rowe PJ, Gaston P, Wade FA. A prospective randomised double-
blind study of functional outcome and range of flexion following total knee replacement with the 
NexGen standard and high flexion components. J Bone Joint Surg Br 2008;90:37-42. 
43. Ladermann A, Lubbeke A, Stern R, Riand N, Fritschy D. Fixed-bearing versus mobile-bearing total 
knee arthroplasty: a prospective randomised, clinical and radiological study with mid-term results at 7 
years. Knee 2008;15:206-10. 
44. Bjorgul K, Novicoff WN, Andersen ST, Ahlund OR, Bunes A, Wiig M, et al. High rate of revision 
and a high incidence of radiolucent lines around Metasul metal-on-metal total hip replacements: Results 
from a randomised controlled trial of three bearings after seven years. Bone Joint J 2013;95 B:881-6. 
45. Breeman S, Campbell MK, Dakin H, Fiddian N, Fitzpatrick R, Grant A, et al. Five-year results of a 
randomised controlled trial comparing mobile and fixed b arings in total knee replacement. Bone Joint J 
2013;95 B:486-92. 
46. Cadossi M, Chiarello E, Savarino L, Tedesco G, Baldini N, Faldini C, et al. A comparison of 
hemiarthroplasty with a novel polycarbonate-urethane acetabular component for displaced 
intracapsular fractures of the femoral neck: a randomised controlled trial in elderly patients.[Erratum 
appears in Bone Joint J. 2013 Nov;95-B(11):1582]. Bone Joint J 2013;95-B:609-15. 
47. Desmarchelier R, Viste A, Chouteau J, Lerat J-L, Fessy M-H. Metasul vs Cerasul bearings: a 
prospective, randomized study at 9 years. J Arthroplasty 2013;28:296-302. 
48. Fischer M, von Eisenhart-Rothe R, Simank HG. Comparable short-term results seen with 
standard and high-flexion knee arthroplasty designs in European patients. J Orthop 2013;10:119-22. 
49. Hamilton DF, Simpson A, Burnett R, Patton JT, Moran M, Clement ND, et al. Lengthening the 
moment arm of the patella confers enhanced extensor mechanism power following total knee 
arthroplasty. J Orthop Res 2013;31:1201-7. 
50. Hansen TB, Stilling M. Equally good fixation of cemented and uncemented cups in total 
trapeziometacarpal joint prostheses. A randomized clinical RSA study with 2-year follow-up. Acta 
Orthopaedica 2013;84:98-105. 
51. Hedbeck CJ, Inngul C, Blomfeldt R, Ponzer S, Tornkvist H, Enocson A. Internal fixation versus 
cemented hemiarthroplasty for displaced femoral neck fractures in patients with severe cognitive 
dysfunction: A randomized controlled trial. J Orthop Traumatol 2013;27:690-5. 
Page 19 of 51
For Peer Review
 
 20 
52. Inngul C, Hedbeck CJ, Blomfeldt R, Lapidus G, Ponzer S, Enocson A. Unipolar hemiarthroplasty 
versus bipolar hemiarthroplasty in patients with displaced femoral neck fractures. A four-year follow-up 
of a randomised controlled trial. Int Orthop 2013;37:2457-64. 
53. Landgraeber S, Quitmann H, Guth S, Haversath M, Kowalczyk W, Kecskemethy A, et al. A 
prospective randomized peri- and post-operative comparison of the minimally invasive anterolateral 
approach versus the lateral approach. Orthop Rev 2013;5:87-92. 
54. Nieuwenhuijse MJ, van der Voort P, Kaptein BL, van der Linden-van der Zwaag HM, Valstar ER, 
Nelissen RG. Fixation of high-flexion total knee prostheses: five-year follow-up results of a four-arm 
randomized controlled clinical and roentgen stereophotogrammetric analysis study. J Bone Joint Surg 
Am 2013;95:e1411-. 
55. Pandit H, Liddle AD, Kendrick BJ, Jenkins C, Price AJ, Gill HS, et al. Improved fixation in 
cementless unicompartmental knee replacement: five-year results of a randomized controlled trial. J 
Bone Joint Surg Am 2013;95:1365-72. 
56. Penny JO, Ovesen O, Varmarken J-E, Overgaard S. Similar range of motion and function after 
resurfacing large-head or standard total hip arthroplasty. Acta Orthop 2013;84:246-53. 
57. Radetzki F, Wienke A, Mendel T, Gutteck N, Delank K-S, Wohlrab D. High flex total knee 
arthroplasty--a prospective, randomized study with results after 10 years. Acta Orthop Belg 
2013;79:536-40. 
58. Smolders JM, Pakvis DF, Hendrickx BW, Verdonschot N, van Susante JL. Periacetabular bone 
mineral density changes after resurfacing hip arthroplasty versus conventional total hip arthroplasty. A 
randomized controlled DEXA study. J Arthroplasty 2013;28:1177-84. 
59. Stiehler M, Goronzy J, Hartmann A, Krummenauer F, Gunther K-P. The First SICOT Oral 
Presentation Award 2011: imageless computer-assisted femoral component positioning in hip 
resurfacing: a prospective randomised trial. Int Orthop 2013;37:569-81. 
60. Vidovic D, Matejcic A, Punda M, Ivica M, Tomljenovic M, Bekavac-Beslin M, et al. Periprosthetic 
bone loss following hemiarthroplasty: A comparison between cemented and cementless hip prosthesis. 
Injury 2013;44:S62-S6. 
61. Hamilton DF, Clement ND, Burnett R, Patton JT, Moran M, Howie CR, et al. Do modern total 
knee replacements offer better value for money? A health economic analysis. Int Orthop 2013;37:2147-
52. 
62. Munzinger U, Guggi T, Kaptein B, Persoon M, Valstar E, Cornelis Doets H. A titanium plasma-
sprayed cup with and without hydroxyapatite-coating: A randomised radiostereometric study of stability 
and osseointegration. Hip Int 2013;23:33-9. 
63. Zagra L, Anasetti F, Bianchi L, Licari V, Giacometti Ceroni R. No difference in gait recovery after 
THA with different head diameters: A prospective randomized study. Clin Orthop Rel Res 
2013;471:3830-7. 
64. Aggarwal AK, Agrawal A. Mobile vs fixed-bearing total knee arthroplasty performed by a single 
surgeon. A 4- to 6.5-year randomized, prospective, controlled, double-blinded study. J Arthroplasty 
2013;28:1712-6. 
65. Chareancholvanich K, Narkbunnam R, Pornrattanamaneewong C. A prospective randomised 
controlled study of patient-specific cutting guides compared with conventional instrumentation in total 
knee replacement. Bone Joint J 2013;95-B:354-9. 
66. Jung W, Chun C, Lee J, Ha J, Jeong JH. The accuracy of the extramedullary and intramedullary 
femoral alignment system in total knee arthroplasty for varus osteoarthritic knee. Knee Surg Sports 
Traumatol Arthrosc 2013;21:629-35. 
67. Kim YH, Park JW, Kulkarni SS. A randomised prospective evaluation of ceramic-on-ceramic and 
ceramic-on-highly cross-linked polyethylene bearings in the same patients with primary cementless total 
hip arthroplasty. Int Orthop 2013;37:2131-7. 
Page 20 of 51
For Peer Review
 
 21 
68. Nishizawa Y, Matsumoto T, Kubo S, Muratsu H, Matsushita T, Oka S, et al. The influence of 
patella height on soft tissue balance in cruciate-retaining and posterior-stabilised total knee 
arthroplasty. Int Orthop 2013;37:421-5. 
69. Roh YW, Kim TW, Lee S, Seong SC, Lee MC. Is TKA using patient-specific instruments comparable 
to conventional TKA? A randomized controlled study of one system. Clin Orthop Rel Res 2013;471:3988-
95. 
70. Song EK, Seon JK, Yim JH, Netravali NA, Bargar WL. Robotic-assisted TKA reduces postoperative 
alignment outliers and improves gap balance compared to conventional TKA knee. Clin Orthop Rel Res 
2013;471:118-26. 
71. Umrani SP, Cho K-Y, Kim K-I. Patellar eversion does not adversely affect quadriceps recovery 
following total knee arthroplasty. J Arthroplasty 2013;28:591-4. 
72. Barrett WP, Turner SE, Leopold JP. Prospective randomized study of direct anterior vs postero-
lateral approach for total hip arthroplasty. J Arthroplasty 2013;28:1634-8. 
73. Dennis DA, Heekin RD, Clark CR, Murphy JA, O'Dell TL, Dwyer KA. Effect of implant design on 
knee flexion. J Arthroplasty 2013;28:429-38. 
74. Hamilton WG, Parks NL, Saxena A. Patient-specific instrumentation does not shorten surgical 
time: A prospective, randomized trial. J Arthroplasty 2013;28:96-100. 
75. Jarvis SL, Johnson-Wo AK, Onstot BR, Bhowmik-Stoker M, Shrader MW, Jacofsky MC, et al. 
Differences between standard and minimally invasive parapatellar surgical approaches for total knee 
arthroplasty in the tasks of sitting and standing. J Knee Surg 2013;26:249-56. 
76. Wegrzyn J, Parratte S, Coleman-Wood K, Kaufman KR, Pagnano MW. The John Insall award: no 
benefit of minimally invasive TKA on gait and strength outcomes: a randomized controlled trial. Clin 
Orthop Rel Res 2013;471:46-55. 
77. Greidanus NV, Chihab S, Garbuz DS, Mas i BA, Tanzer M, Gross AE, et al. Outcomes of minimally 
invasive anterolateral THA are not superior to those of minimally invasive direct lateral and 
posterolateral THA hip. Clin Orthop Relat Res 2013;471:463-71. 
78. Lapner PLC, Sabri E, Rakhra K, Bell K, Athwal GS. Healing rates and subscapularis fatty infiltration 
after lesser tuberosity osteotomy versus subscapularis pe l for exposure during shoulder arthroplasty. J 
Shoulder Elbow Surg 2013;22:396-402. 
79. Naudie DDR, Somerville L, Korczak A, Yuan X, McCalden RW, Holdsworth D, et al. A Randomized 
trial comparing acetabular component fixation of two porous ingrowth surfaces using RSA. J 
Arthroplasty 2013;28:48-52. 
80. Vendittoli PA, Riviere C, Lavigne M, Lavoie P, Alghamdi A, Duval N. Alumina on alumina versus 
metal on conventional polyethylene: a randomized clinical trial with 9 to 15 years follow-up. Acta 
Orthop Belg 2013;79:181-90. 
81. Joseph J, Simpson PMS, Whitehouse SL, English HW, Donnelly WJ. The use of navigation to 
achieve soft tissue balance in total knee arthroplasty - A randomised clinical study. Knee 2013;20:401-6. 
82. Soliman OA, Koptan WMT. Proximal humeral fractures treated with hemiarthroplasty: does 
tenodesis of the long head of the biceps improve results? Injury 2013;44:461-4. 
83. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for 
improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001;134:657-62. 
84. Yao AC, Khajuria A, Camm CF, Edison E, Agha R. The reporting quality of parallel randomised 
controlled trials in ophthalmic surgery in 2011: a systematic review. Eye (Lond) 2014;28:1341-9. 
85. Liu LQ, Morris PJ, Pengel LH. Compliance to the CONSORT statement of randomized controlled 
trials in solid organ transplantation: a 3-year overview. Transpl Int 2013;26:300-6. 
86. Agha RA, Camm CF, Doganay E, Edison E, Siddiqui MR, Orgill DP. Randomised controlled trials in 
plastic surgery: a systematic review of reporting quality. Eur J Plast Surg 2014;37:55-62. 
Page 21 of 51
For Peer Review
 
 22 
87. Zavitsanos PJ, Bird VG, Mince KA, Neuberger MM, Dahm P. Low methodological and reporting 
quality of randomized, controlled trials of devices to treat urolithiasis. J Urol 2014;191:988-93. 
88. Lee SY, Teoh PJ, Camm CF, Agha RA. Compliance of randomized controlled trials in trauma 
surgery with the CONSORT statement. J Trauma Acute Care Surg 2013;75:562-72. 
89. Kiehna EN, Starke RM, Pouratian N, Dumont AS. Standards for reporting randomized controlled 
trials in neurosurgery. J Neurosurg 2011;114:280-5. 
90. Camm CF, Chen Y, Sunderland N, Nagendran M, Maruthappu M, Camm AJ. An assessment of the 
reporting quality of randomised controlled trials relating to anti-arrhythmic agents (2002-2011). Int J 
Cardiol 2013;168:1393-6. 
91. Hopewell S, Dutton S, Yu LM, Chan AW, Altman DG. The quality of reports of randomised trials 
in 2000 and 2006: comparative study of articles indexed in PubMed. Bmj 2010;340:c723. 
92. Peters JP, Hooft L, Grolman W, Stegeman I. Assessment of the quality of reporting of 
randomised controlled trials in otorhinolaryngologic literature - adherence to the CONSORT statement. 
PLoS One 2015;10:e0122328. 
93. Chan AW, Altman DG. Epidemiology and reporting of randomised trials published in PubMed 
journals. Lancet 2005;365:1159-62. 
94. Montgomery S. Of towers, walls, and fields: perspectives on language in science. Science 
2004;303:1333-5. 
 
Page 22 of 51
For Peer Review
 
 1
Title 
Outcome measures used in arthroplasty trials: Systematic review of the 2008 and 2013 literature 
 
Running Title: Outcome measures in arthoplasty RCTs  
 
Authors 
Bethan L Richards
1,2
,  FRACP, MClinEpi, MSportsMed 
    Bethan.Richards@sswahs.nsw.gov.au 
Peter DH Wall
3  
MBChB  (Hons), MRCS  (Edin), PhD 
    pdhwall@gmail.com 
Andrew Sprowson
3*  
MD, FRCS 
    A.P.Sprowson@warwick.ac.uk
 
Jasvinder A Singh
4,5
,  MD, MPH 
    jassingh@uab.edu 
Rachelle Buchbinder
6,7  
FRACP, MD 
    rachelle.buchbinder@monash.edu 
 
*
Dr Sprowson died March 13th, 2015
 
 
Affiliations 
1. Institute of Rheumatology and Orthopaedics, Royal Prince Alfred Hospital, Sydney, 
Australia 
2. Sydney Medical School, University of Sydney, Sydney, Australia 
Page 23 of 51
For Peer Review
 
 2
3. Birmingham Veterans Affairs Warwick Orthopaedics, University of Warwick, Coventry, 
UK. 
4. Medical Center and University of Alabama at Birmingham, Birmingham, Alabama, USA 
5. Mayo Clinic College of Medicine, Rochester, MN, USA 
6. Department of Epidemiology and Preventive Medicine, School of Public Health & 
Preventive Medicine, Monash University, VIC Australia 
7. Monash Department of Clinical Epidemiology, Cabrini Hospital, Melbourne, VIC, Australia. 
 
Conflict of interest statement 
JAS has received research grants from Takeda and Savient and consultant fees from Savient, 
Takeda, Regeneron, Merz, Iroko, Bioiberica, Crealta/Horizon and Allergan pharmaceuticals, 
WebMD, UBM LLC and the American College of Rheumatology.  JAS serves as the principal 
investigator for an investigator-initiated study funded by Horizon pharmaceuticals through a 
grant to DINORA, Inc., a 501 (c)(3) entity.  JAS is a member of the executive of OMERACT, an 
organization that develops outcome measures in rheumatology and receives arms-length funding 
from 36 companies; a member of the American College of Rheumatology's (ACR) Annual 
Meeting Planning Committee (AMPC); Chair of the ACR Meet-the-Professor, Workshop and 
Study Group Subcommittee; and a member of the Veterans Affairs Rheumatology Field 
Advisory Committee.  JAS is the editor and Director of the UAB Cochrane Musculoskeletal 
Group Satellite Center on Network Meta-analysis.  
All other authors certify that he or she has no commercial associations  (e.g., consultancies, stock 
ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of 
interest in connection with the submitted article. 
Page 24 of 51
For Peer Review
 
 3
 
Word Count: 3282  (excluding Abstract) 
 
Corresponding Author: 
Dr Bethan L Richards 
Bethan.Richards@sswahs.nsw.gov.au 
 
  
Page 25 of 51
For Peer Review
 
 4
Abstract 
Background/objective: Previously published literature assessing the reporting of outcome 
measures used in joint replacement randomised controlled trials  (RCTs) has revealed 
disappointing results.  It remains unknown as to whether international initiatives have led to any 
improvement in the quality of reporting and/or a reduction in the heterogeneity of outcome 
measures used. Our objective was to systematically assess and compare primary outcome 
measures and risk of bias of joint replacement RCTs published in 2008 and 2013.  
Methods: We searched MEDLINE, EMBASE and CENTRAL for RCTs investigating adult 
patients undergoing joint replacement surgery. Two authors independently identified eligible 
trials, extracted data and assessed risk of bias using the Cochrane tool.  
Results: Seventy RCTs  (30 in 2008; 40 in 2013) met the eligibility criteria.  There was no 
significant difference in the number of trials judged to be at low overall risk of bias  (N=6, 20%) 
in 2008 compared with six  (15%) in 2013  (χ
2
=0.302, P=0.75). Significantly more trials 
published in 2008 did not specify a primary outcome measure  (N=25, 83%) compared with 18  
(45%) trials in 2013, χ
2
= 10.6316, P=0.001).  When specified, there was significant 
heterogeneity in the measures used to assess primary outcomes.  
Conclusion:  While less than a quarter of trials published in both 2008 and 2013 were judged to 
be at low overall risk of bias, significantly more trials published in 2013 specified a primary 
outcome. Although this might represent a temporal trend towards improvement, the overall 
frequency of primary outcome reporting and the wide heterogeneity in primary outcomes 
reported remain suboptimal.  
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Introduction 
With an expanding and aging population, an escalating prevalence of obesity and a rising need 
for both initial and joint revision surgery, the incidence and associated economic burden of joint 
replacement surgery has been projected to increase exponentially(1). For many patients, joint 
replacement surgery is an effective management option to reduce pain, restore function and 
improve quality of life. However, individuals who undergo joint replacement are also at risk for 
a variety of adverse events associated with both the anaesthetic and the surgery. With expanding 
indications for joint replacement and the continuing evolution of surgical techniques and 
implants, many important research questions need to be answered. To address these issues there 
is an ongoing need for high quality trials within this field of orthopaedics. 
 
Randomised controlled trials  (RCTs) are widely acknowledged to be the best type of trial design 
to evaluate the effectiveness and safety of health care interventions.(2-5) However, the RCT’s 
ability to answer important clinical questions will always be limited by its design and the 
outcome measures used. To draw meaningful conclusions from individual RCTs, relevant, robust 
and validated outcomes measures are required. In addition, these outcomes should be pre-
specified and clearly reported as to whether they are primary or secondary. This enables readers 
to assess whether the RCT is adequately powered and avoids the perception of selective 
reporting bias. 
 
In the field of joint replacement surgery, previously published literature assessing the reporting 
frequency, relevance and homogeneity of outcome measures used has revealed disappointing 
results(6).  Specifically, primary outcomes were often not specified, and when they were, there 
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was significant heterogeneity in the types of outcomes measures used to assess the same 
endpoint.  To address this on a large scale, several multi-national collaborations and initiatives 
have been established. For example, following the poor findings in their systematic review, 
Riddle and colleagues proposed that consensus from an international group of experts involved 
in the care of these patients was needed(7). In 2008 a working group within Outcome Measures 
in Rheumatology  (OMERACT) and Osteoarthritis Research Society International  (OARSI) was 
established with the aim of improving the reporting of relevant, evidence based health outcome 
domains within joint replacement trials(8).  In addition, to facilitate accurate, complete, and 
transparent reporting of all clinical trials, in 2008 the EQUATOR  (Enhancing the Quality and 
Transparency of Health Research) Network was launched and in 2010 the Consolidated 
Standards of Reporting Trials  (CONSORT) Statement  (first published in 1996) was published 
to provide researchers with a check list of 25 items to facilitate complete and transparent 
reporting of trial findings(9).   
 
It remains unknown as to whether these international initiatives have led to any improvement in 
the quality of joint replacement trial reporting and/or a reduction in the heterogeneity of outcome 
measures used. To investigate this question and inform the OMERACT 2014 Working Group 
meeting  (which aimed to define an internationally agreed upon core set of domains and outcome 
measures that should be reported in every joint replacement clinical trial)(10), we performed a 
systematic review of outcomes that had been reported in joint replacement trials published in 
2008 and 2013. This paper reports the risk of bias of included trials and assesses and compares 
their primary outcomes. A separate paper will report the extent to which all reported outcomes 
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met the OMERACT criteria of truth, discrimination, and feasibility and map the reported 
outcomes to OMERACT Filter 2.0(11).  
 
Methods  
Search Strategy and Criteria 
This systematic review was performed in accordance with the PRISMA  (Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses) format(12) and the protocol was 
prospectively registered with the International Prospective Register of Systematic Reviews  
(PROSPERO) Registration number: CRD42014009216.  This study did not require ethics 
committee approval , since it does not involve any human or animals and is a systematic review 
of published articles in the medical literature.  
 
All randomised or quasi-randomised  (where allocation not strictly random) controlled trials 
investigating adult patients undergoing joint replacement surgery  (defined as substitution of any 
joint surface with a prosthesis) were identified. Trials were included if the comparator was 
another type of joint implant, surgical placebo or sham, usual care, physical therapy or other 
active treatment and at least one outcome had been reported. Studies were excluded if they 
evaluated spinal joint replacement surgery, had a primary intervention of interest that was not the 
insertion of a joint prosthesis  (e.g. trials investigating pre-operative education, peri-operative 
analgesia or post-operative care) or were not published as a full report in English.  
 
An electronic literature search for articles published in 2008 and 2013 was performed in 
MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials  (CENTRAL) 
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using a comprehensive search strategy (Table 1). We also performed a hand search of reference 
lists of relevant articles to identify additional relevant trials.  
 
Two authors  (BR and PW) independently screened the titles and abstracts of all studies 
identified by the search strategy and then independently reviewed the full text of all potentially 
eligible studies to identify studies that fulfilled inclusion criteria. Any disagreement in study 
selection was resolved by consensus or by discussion with a third reviewer (RB). 
 
The same two authors independently extracted data from the included using predetermined 
forms. Differences in data extraction were resolved by referring back to the original articles and 
establishing a consensus. A third reviewer  (RB) was consulted to help resolve differences as 
necessary. The information extracted included study site, funding, enrolment date, size, design, 
population, interventions, and outcome measures  (and whether they were pre-specified). Each 
outcome was recorded as either primary or secondary. An outcome was recorded as primary if it 
was reported as a “primary outcome” in the manuscript or registered protocol or was used to 
calculate the sample size. More than one primary outcome could be recorded provided these 
criteria were met.  
 
Two authors  (BR and PW) independently assessed risk of bias for all included studies using 
methods recommended by the Cochrane Collaboration,(13) which assess the following key 
criteria: random sequence generation, allocation concealment, blinding of participants, care 
provider and outcome assessor for each outcome measure, incomplete outcome data, selective 
outcome reporting  and other sources of bias. Other sources of bias that were considered included 
Page 30 of 51
For Peer Review
 
 9
whether or not co-interventions and adherence to treatment (e.g. for analgesics and physical 
therapy programs) were assessed and reported to be equal between groups, and sources of 
funding. Each criterion was rated as low risk of bias, high risk of bias, or unclear risk  (indicating 
either lack of information or uncertainty over the potential for bias). Information to inform the 
risk of bias rating was sourced from searching trial registries and the published papers. 
An assessment of overall risk of bias was made where low overall risk of bias indicated plausible 
bias unlikely to seriously alter the results  (low risk of bias for all key domains), unclear overall 
risk of bias indicated plausible bias that raises some doubt about the results  (unclear risk of bias 
for one or more key domains) and high overall risk of bias indicating plausible bias seriously 
weakens confidence in the results  (high risk of bias for one or more key domains)(13). A third 
reviewer  (RB) was consulted to resolve differences as necessary.  
Data Analysis 
A descriptive analysis of the primary outcomes was p rformed which compared frequency and 
description of primary outcome measures by site of joint replacement and year. Comparison of 
2008 and 2013 results for overall risk of bias and number of trials reporting primary outcomes 
was made using Pearson chi-squared tests. We also used the Pearson chi-squared test to 
determine whether an association might exist between overall risk of bias and reporting of 
primary outcomes. 
 
Results 
The search strategy identified 1635 studies. Of these 70 randomised controlled trials  (30 with 
2,789 participants published in 2008 and 40 with 4253 participants published in 2013), met the 
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eligibility criteria and were included in the review. A PRISMA flow diagram of the searches 
through to the final inclusion is shown in Figure 1. The summary characteristics of the included 
trials according to their year of publication are shown in Table 2. 
 
Study characteristics of trials published in 2008 
Eighteen  (60%) of the 30 trials published in 2008 were conducted in Europe (14-26), six (20%) 
in the USA(27-32), two (7%) each in Asia(33, 34) and Canada (35, 36) and one (3%) each in 
Australia(37) and New Zealand(38). Twenty (67%) trials were independently funded(14-17, 19, 
20, 22-24, 26-28, 30-32, 34, 35, 37-39) , 9 (30%) had industry funding(17, 18, 21, 29, 31, 36, 40-
42) and in one trial the source of funding was unclear(25). The year of first recruitment ranged 
from 1994 to 2007 (median, 2001). The most common joint evaluated was the knee  (N= 19, 
63%)(17-24, 26, 29, 30, 33-37, 39, 42, 43), followed by the hip  (N=10, 33%)(14-16, 27, 28, 31, 
32, 38, 40, 41), and one trial (3%) evaluated the shoulder(25).  There were no trials evaluating 
joint replacement surgery of the elbow, wrist, hand, ankle or foot. Fifteen (50%) trials evaluated 
two or more different prostheses or components(14, 16-19, 25, 26, 30, 31, 38-43), 13 (43%) 
evaluated the same prosthesis but used differing surgical techniques(20-24, 27-29, 33-37) and 
two (1%) evaluated joint replacement versus other joint surgeries(15, 32).  
 
Study Characteristics of trials published in 2013 
Twenty  (50%) of the 40 trials published in 2013 were conducted in Europe(44-63), nine (23%) 
in Asia(64-71), five (13%) in the USA(72-76), four (10%) in Canada(77-80), and one (3%) each 
in Australia(81) and the Middle East(82). Twelve (30%) trials were industry funded(45, 52, 54-
56, 59, 62, 63, 70, 73, 77, 80), 15 (38%) had independent funding(44, 46, 48, 50, 51, 53, 57, 60, 
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64, 65, 69, 72, 78, 81, 82) and in 13 (33%) trials the source of funding was not specified(47, 49, 
58, 61, 66-68, 70, 71, 74-76, 79). The year of first recruitment ranged from 1996 to 2011  
(median, 2007). The knee (n= 20, 50%)(45, 48, 49, 54, 55, 57, 61, 64-66, 68-71, 73-76, 81) and 
hip  (N=17, 43%)(44, 46, 47, 51-53, 56, 58-60, 62, 63, 67, 72, 77, 79, 80) were again the most 
commonly studied joints, with two trials (5%) studying the shoulder(78, 82) and one (3%) 
studying the wrist(50).  There were no trials evaluating joint replacement surgery of the elbow, 
hand, ankle or foot. Eighteen (43%) trials evaluated two or more different prostheses or 
components(44, 45, 47-50, 52, 54, 56, 57, 61-64, 67, 73, 79, 80), 20 (50%) evaluated the same 
prosthesis but used differing surgical techniques(53, 55, 58-60, 65, 66, 68-72, 74-78, 81, 82) and 
two (5%) evaluated joint replacement versus other joint surgeries(46, 51). 
 
Risk of Bias 
Of the 30 trials published in 2008, 6 (20%) were judged to be at low overall risk of bias, and the 
remainder were all judged to be at high or unclear overall risk of bias (Figure 2). Four (21%) of 
the 19 knee trials(36, 39, 42, 43), and 2 (20%) of the 10 hip trials were judged to be low risk of 
bias(40, 41). In the one shoulder joint trial(25), the risk of bias was deemed unclear. 
 
Of the 40 trials published in 2013, only six (15%) were judged to be at low overall risk of bias  
(Figure 3). Three (15%) of the 20 knee trials were judged to be at low overall risk of bias(56, 58, 
77), 11 (55%) were deemed unclear(48, 57, 64, 66, 68-70, 73, 76, 81) and 6 (30%) were judged 
to be at high risk of bias(49, 54, 61, 71, 74, 75). Three  (21%) of the 17 hip trials were judged to 
be at low overall risk of bias(56, 58, 77), six  (43%) were deemed unclear(46, 47, 59, 60, 62, 80) 
and eight  (57%) were judged to be at high risk of bias(44, 51-53, 63, 67, 72, 79).  One shoulder 
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trial was deemed unclear(82) and one was judged to be at high overall risk of bias(78), while the 
single wrist trial was also judged to be at high overall risk of bias(50).  
 
Figure 4 compares the number of trials with low risk of bias for each risk of bias domain and 
overall low risk of bias according to publication year. There was no difference between years in 
number of trials judged to be at overall low risk of bias (6/30 in 2008 compared with 6/40 in 
2013, χ
2
 0.302, P=0.75). The method used to generate the random sequence was adequately 
reported in 63% of the 2008 trials and 53% of the 2013 trials, however details of allocation 
concealment were reported in only 10 (33%) trials in 2008 and 12 (30%) trials in 2013. More 
trials reported blinding of patients (13, 33%) and outcomes (N=14, 35%) in 2013 in comparison 
with 2008 (N=17 (23%) and 4  (13%) respectively).  Twenty-six (87%) trials in 2008 reported 
detailed baseline characteristics however this only applied to 22 (55%) of the 2013 trials. Few 
trials pre-specified or reported the use of relevant co-interventions (N=13, 43%) in 2008; N=9, 
22% in 2013), or described how incomplete data were addressed  (N=4, 13% in 2008; N=14, 
35% in 2013). Several trials also had evidence of selective outcome reporting (N=11, 37% in 
2008; N=9, 22% in 2013). These issues may have influenced outcomes.  
 
Primary Outcomes 
A summary of the primary outcomes reported in the 2008 and 2013 trials is shown in Table 3. 
Compared with trials published in 2008, more trials published in 2013 reported a primary 
outcome  (N=22/40 (55%) compared with N=5/30 (17%), χ
2
= 10.6316, P=0.001). Four out of 19  
(21%) knee trials specified a primary outcome in 2008 compared with 11/20 (55%) knee trials in 
2013. In these 15 knee trials, 17 different primary outcomes were specified despite evaluating 
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similar questions. Within each time period only two trials reported the same primary outcome  
(knee range of motion was specified in two trials in 2008 and difference in mechanical axis 
deviation measured in degrees in the coronal plane on x-ray in two trials in 2013). No primary 
outcome was used in both time periods. The majority of primary outcomes reported evaluated 
technical aspects of the procedures (N=12/17, 71%), rather than patient centred outcomes. 
 
Only one out of 10 (10%) hip trials reported a primary outcome in 2008 compared with 8/17  
(47%) hip trials in 2013.  Similar to the knee trials, the primary outcomes varied widely and were 
focussed on technical outcomes of the procedure. Primary outcomes used in more than one hip 
trial included component migration  (RSA) (N=3), deviation ≥5 degrees of planned stem shaft 
angle  (x-ray) (N=2), computerized gait assessment  (mean gait velocity, stride length) (N=2) and 
revision rates (N=2). Assessment of component migration was the only primary outcome 
measure utilised in both time periods. 
 
Two of the three shoulder trials reported a primary outcome. Only the two 2013 trials evaluating 
shoulder joint replacement surgery reported a primary outcom , and each trial used a different 
measures to assess “improvement”  (post-operative pain on a VAS 0-10mm and healing rate of 
the subscapularis tendon visualised on MRI). The single wrist trial reported a primary outcome 
and used RSA to measure component migration in mm. 
 
Discussion 
We observed a significant difference in the frequency of reporting of primary outcomes in joint 
replacement trials in 2013 compared with 2008. Only 17% (21% knee and 10% hip) of RCTs 
Page 35 of 51
For Peer Review
 
 14 
published in 2008 reported a primary outcome measure in comparison with 55% (55% knee and 
47% hip) in 2013.  Without knowledge of the frequency of reporting before 2008 and between 
2008 and 2013 it is not possible to know with certainty whether or not the improved reporting in 
2013 reflects a real improvement over time. Nevertheless almost half of all joint replacement 
trials continue to fail to specify a primary outcome despite widely accepted CONSORT 
recommendations(9, 83). Similar inadequate reporting of primary outcomes have been shown in 
other surgical fields including ophthalmic surgery(84), solid organ transplantation(85), plastic 
surgery(86), urology(87), trauma surgery(88) and neurosurgery(89). 
  
In addition, we found that among trials that did specify one or more primary outcomes, these 
varied widely despite the trials addressing similar research questions. In both years  (2008 and 
2013), no primary outcome measure was used in more than two trials despite similar research 
questions. This heterogeneity in primary outcome reporting is consistent with results from a 
previous systematic review(6).  Heterogeneity in outcome measurement hampers our ability to 
combine, contrast and accurately interpret the results from multiple RCTs answering the same  
(and sometimes, similar) research questions. To improve the quality of information available for 
patients undergoing joint replacement surgery, RCTs evaluating the same clinical questions need 
to utilise a homogenous set of outcome measures. Further efforts are required to achieve this(10).   
 
Furthermore, the majority of primary outcomes reported were predominantly focussed upon 
technical aspects of the surgery. Hence, despite the significant investment of time, money and 
resources in evaluating these important research questions, we found that the majority of trials in 
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this systematic review were not designed nor powered to evaluate other important core domains 
of health for both the patient and society.   
 
Few trials published in both 2008 and 2013 were judged to be at low overall risk of bias  (20% in 
2008 and 15% in 2013). Not surprisingly, the trials at less potential for bias were more likely to 
report a primary outcome measure. In addition almost a quarter of the trials we included trials  
(20/70, 23%) were judged to be at unclear risk of bias as they reported insufficient information.  
While it is often not possible in surgical RCTs to blind the investigators to the group 
assignments, or standardize surgical techniques, it should be possible to minimise other potential 
sources of bias. Common areas of potential bias occurring in more than 50% of the studies 
included failing to describe allocation concealment, participant blinding, how incomplete data 
were addressed, and selective reporting of outcomes. Lack of adequate reporting of details of 
randomisation, allocation concealment, blinding, co-intervention use and outcomes is not limited 
to joint replacement trials or orthopaedic surgery(84, 87-93). 
 
Our study has several limitations. Firstly, while we used a comprehensive systematic search 
strategy to identify all relevant studies, we excluded foreign language publications. Given the 
high proportion of papers published in English language journals  (80–90%) this is unlikely to 
affect generalisability(94). Secondly, the majority of joint replacement trials in this review 
involved hip and knee surgery. There were limited trials evaluating the shoulder, wrist and hand, 
and no trials evaluating elbow or ankle joint replacement. Therefore our results may or may not 
be generalisable to joint replacement trials of other joints. Thirdly, in selecting two publication 
years, there is a possibility that this literature may not have been truly representative of periods 
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just before, between and after these dates. The five year gap between study years may not have 
been long enough to capture meaningful change; however we chose the start year as the year of 
publication of the study that showed poor quality of arthroplasty trials (6). More studies may be 
needed in the future with a longer interval to look for improvements using the same quality 
criteria. Our results are however consistent with previous reviews. Finally, we judged risk of bias 
and specification of primary outcomes on the basis of the published paper. It may be that we 
overestimated potential for bias and underestimated frequency of primary outcome specification 
due to poor reporting practices rather than suboptimal trial methodology. However we tried to 
limit this effect by also searching the trial registries for protocols.  
 
In conclusion, despite an observed increase in frequency of reporting of primary outcome 
measures in joint replacement trials in 2013 compared with 2008, almost 50% of trials published 
in 2013 did not report their primary outcomes. In addition among trials that did report primary 
outcomes, these were heterogeneous, frequently measured technical aspects of surgery rather 
than patient important endpoints and few trials used the same primary outcome even for similar 
research questions. In addition the majority of trials published in both years were at high or 
unclear overall risk of bias and reflect a lack of implementation of quality improvement 
initiatives such as the CONSORT guidelines  (or similar). Further efforts are needed to improve 
the quality of joint replacement trials and ensure primary outcomes are reported. A standardised, 
universally accepted core set of outcomes to be used in all joint replacement trials, based upon 
their clinical relevance would enhance this field.  
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Table 1: Search Strategy for Medline and EMBASE  
Medline 
 
Embase 
 
1. exp Arthroplasty/ 
2. arthroplast$.tw. 
3. exp Joint Prosthesis/ 
4. (knee and (replace$ or arthroplast$ or 
prosthe$ or endoprosthe$ or implant)).tw. 
5. (hip and (replace$ or arthroplast$ or 
prosthe$ or endoprosthe$ or implant)).tw. 
6. (elbow and (replace$ or arthroplast$ or 
prosthe$ or endoprosthe$ or implant)).tw. 
7. (shoulder and (replace$ or arthroplast$ or 
prosthe$ or endoprosthe$ or implant)).tw. 
8. (joint and (replace$ or arthroplast$ or 
prosthe$ or endoprosthe$ or implant)).tw. 
9. (tka or tkr or total knee or total hip).tw. 
10. or/1-9 
11. randomized controlled trial.pt. 
12. controlled clinical trial.pt. 
13. randomized.ab. 
14. placebo.ab. 
15. drug therapy.fs. 
16. randomly.ab. 
17. trial.ab. 
18. groups.ab. 
19. or/11-18 
20. exp animals/ not humans.sh. 
21. 19 not 20 
22. 10 and 21 
23. limit 22 to "all adult (19 plus years)" 
24. limit 23 to english 
25. limit 24 to yr="2008" 
#1 arthroplasty'/exp OR 'arthroplasty' 
#2 total AND knee AND replacement 
#3 joint AND replacement 
#4 joint AND prosthesis 
#5 replacement* OR arthroplast* OR prosthe* 
OR implant OR endoprosthe* AND knee 
#6 replacement* OR arthroplast* OR prosthe* 
OR implant OR endoprosthe* AND hip 
#7 replacement* OR arthroplast* OR prosthe* 
OR implant OR endoprosthe* AND elbow 
#8 replacement* OR arthroplast* OR prosthe* 
OR implant OR endoprosthe* AND  shoulder 
#9 tka 
#10 tha 
#11 total AND hip AND replacement 
#12 knee AND prosthesis 
#13 hip AND prosthesis 
#14 #1 OR #2 OR #3 OR #4 OR #6 OR #7 OR 
#8 OR #9 OR #10 OR #11 OR #12 OR #13 
OR #14 
#15 randomized AND controlled AND trial 
#16 randomization 
#17 double AND blind AND procedure 
#18 single AND blind AND procedure 
#19 #15 OR #16 OR #17 OR #18 
#20 animal NOT human 
#21 #19 NOT #20 
#22 #14 AND #19 AND #21 
#23 #22 AND ([adult]/lim OR [aged]/lim OR 
[middle aged]/lim OR [very elderly]/lim) AND 
2008:py 
#24 #22 AND ([adult]/lim OR [aged]/lim OR 
[middle aged]/lim OR [very elderly]/lim) AND 
2013:py 
#25 english:la 
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Table 2: Characteristics of joint replacement randomised controlled trials published in 2008 and 
2013  
 
 
2008 (N=30) 2013 (N=40) 
Year of first recruitment 
(Range, (median)) 1994 – 2007 (2001) 1996 – 2011 (2007) 
Number of participants 
(median, range) 85 (14-284) 81 (28-539) 
Region 
Europe 
Asia 
USA 
Canada 
Middle East 
Australia 
N (%) 
18 (60) 
2 (7) 
 6 (20) 
2 (7) 
0 (0) 
 2 (7) 
N (%) 
20 (50) 
9 (23) 
5 (13) 
4 (10) 
1 (3) 
1 (3) 
Funding 
Independent 
Industry funded 
Not specified 
 
20 (67) 
9 (30) 
 1 (3)  
  
15 (38) 
12 (30) 
13 (33) 
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Figure 1. PRISMA diagram showing selection of included trials 
 
 
 
2008 
CCTR, Medline, EMBASE,  
n=749 
For detailed review 
n=39 
Included n=30 
Excluded n=9 
• Non-arthroplasty 
intervention 
• Non-English language 
Excluded n=710 
• No outcome of interest 
• No c ntrol group 
• Non-English language 
2013 
CCTR, Medline, EMBASE, 
n=886 
Excluded n=842 
• No outcome of interest 
• No control group 
• Non-English language 
For detailed review 
n=44 
Excluded n=4 
• Non-arthroplasty 
intervention 
 
Included n=40 
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Figure 2. The Risk of Bias summary of included joint replacement trials in 2008 
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Figure 3. The Risk of Bias summary of included joint replacement trials in 2013  
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Figure 4: Number of trials with low risk of bias for different criteria in the Cochrane Risk of Bias tool 
comparing 2008 and 2013 joint replacement randomised controlled trials  
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